204 related articles for article (PubMed ID: 24218134)
1. Hepcidin-25 concentrations are markedly increased in patients with chronic kidney disease and are inversely correlated with estimated glomerular filtration rates.
Troutt JS; Butterfield AM; Konrad RJ
J Clin Lab Anal; 2013 Nov; 27(6):504-10. PubMed ID: 24218134
[TBL] [Abstract][Full Text] [Related]
2. Hepcidin and proinflammatory markers in children with chronic kidney disease: A case-control study
.
Goyal KK; Saha A; Sahi PK; Kaur M; Dubey NK; Goyal P; Upadhayay AD
Clin Nephrol; 2018 May; 89(5):363-370. PubMed ID: 29451472
[TBL] [Abstract][Full Text] [Related]
3. Serum Hepcidin and Iron Indices Affect Anemia Status Differently According to the Kidney Function of Non-Dialysis Chronic Kidney Disease Patients: Korean Cohort Study For Outcome in Patients with Chronic Kidney Disease (KNOW-CKD).
Lee SW; Kim YH; Chung W; Park SK; Chae DW; Ahn C; Kim YS; Sung SA
Kidney Blood Press Res; 2017; 42(6):1183-1192. PubMed ID: 29227972
[TBL] [Abstract][Full Text] [Related]
4. Hepcidin--a potential novel biomarker for iron status in chronic kidney disease.
Zaritsky J; Young B; Wang HJ; Westerman M; Olbina G; Nemeth E; Ganz T; Rivera S; Nissenson AR; Salusky IB
Clin J Am Soc Nephrol; 2009 Jun; 4(6):1051-6. PubMed ID: 19406957
[TBL] [Abstract][Full Text] [Related]
5. Targeting the hepcidin-ferroportin pathway in anaemia of chronic kidney disease.
Sheetz M; Barrington P; Callies S; Berg PH; McColm J; Marbury T; Decker B; Dyas GL; Truhlar SME; Benschop R; Leung D; Berg J; Witcher DR
Br J Clin Pharmacol; 2019 May; 85(5):935-948. PubMed ID: 30677788
[TBL] [Abstract][Full Text] [Related]
6. Association of hepcidin and anemia in early chronic kidney disease.
Sonkar SK; Singh NK; Sonkar GK; Pandey S; Bhosale V; Kumar A; Usman K
Saudi J Kidney Dis Transpl; 2019; 30(2):315-324. PubMed ID: 31031367
[TBL] [Abstract][Full Text] [Related]
7. Hepcidin and disordered mineral metabolism in chronic kidney disease.
Carvalho C; Isakova T; Collerone G; Olbina G; Wolf M; Westerman M; Gutiérrez OM
Clin Nephrol; 2011 Aug; 76(2):90-8. PubMed ID: 21762639
[TBL] [Abstract][Full Text] [Related]
8. Serum hepcidin-25 and response to intravenous iron in patients with non-dialysis chronic kidney disease.
Chand S; Ward DG; Ng ZY; Hodson J; Kirby H; Steele P; Rooplal I; Bantugon F; Iqbal T; Tselepis C; Drayson MT; Whitelegg A; Chowrimootoo M; Borrows R
J Nephrol; 2015 Feb; 28(1):81-8. PubMed ID: 24687402
[TBL] [Abstract][Full Text] [Related]
9. Hepcidin Response to Iron Therapy in Patients with Non-Dialysis Dependent CKD: An Analysis of the FIND-CKD Trial.
Gaillard CA; Bock AH; Carrera F; Eckardt KU; Van Wyck DB; Bansal SS; Cronin M; Meier Y; Larroque S; Roger SD; Macdougall IC
PLoS One; 2016; 11(6):e0157063. PubMed ID: 27276035
[TBL] [Abstract][Full Text] [Related]
10. Impact of Inflammation on Ferritin, Hepcidin and the Management of Iron Deficiency Anemia in Chronic Kidney Disease.
Ueda N; Takasawa K
Nutrients; 2018 Aug; 10(9):. PubMed ID: 30150549
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow iron distribution, hepcidin, and ferroportin expression in renal anemia.
Bârsan L; Stanciu A; Stancu S; Căpuşă C; Brătescu L; Mandache E; Radu E; Mircescu G
Hematology; 2015 Oct; 20(9):543-52. PubMed ID: 25745821
[TBL] [Abstract][Full Text] [Related]
12. Hepcidin and risk of anemia in CKD: a cross-sectional and longitudinal analysis in the CKiD cohort.
Atkinson MA; Kim JY; Roy CN; Warady BA; White CT; Furth SL
Pediatr Nephrol; 2015 Apr; 30(4):635-43. PubMed ID: 25380788
[TBL] [Abstract][Full Text] [Related]
13. Serum hepcidin level correlates with hyperlipidemia status in patients following allograft renal transplantation.
Xue D; He X; Zhou C
Transplant Proc; 2014; 46(1):156-9. PubMed ID: 24507043
[TBL] [Abstract][Full Text] [Related]
14. Serum hepcidin-25 levels in patients with chronic kidney disease are independent of glomerular filtration rate.
Peters HP; Laarakkers CM; Swinkels DW; Wetzels JF
Nephrol Dial Transplant; 2010 Mar; 25(3):848-53. PubMed ID: 19854845
[TBL] [Abstract][Full Text] [Related]
15. Acute-Phase Proteins and Iron Status in Cats with Chronic Kidney Disease.
Javard R; Grimes C; Bau-Gaudreault L; Dunn M
J Vet Intern Med; 2017 Mar; 31(2):457-464. PubMed ID: 28140480
[TBL] [Abstract][Full Text] [Related]
16. The relation of hepcidin to iron disorders, inflammation and hemoglobin in chronic kidney disease.
Mercadal L; Metzger M; Haymann JP; Thervet E; Boffa JJ; Flamant M; Vrtovsnik F; Houillier P; Froissart M; Stengel B;
PLoS One; 2014; 9(6):e99781. PubMed ID: 24978810
[TBL] [Abstract][Full Text] [Related]
17. Hepcidin/Ferritin Ratios Differ Among Non-Dialyzed Chronic Kidney Disease Patients, and Patients on Hemodialysis and Peritoneal Dialysis.
Niikura T; Maruyama Y; Nakashima S; Matsuo N; Tanno Y; Ohkido I; Yokoyama K; Yamamoto H; Yokoo T
Ther Apher Dial; 2019 Aug; 23(4):341-346. PubMed ID: 30411489
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of serum NGAL and hepcidin levels in chronic kidney disease patients.
Avci Çiçek E; Rota S; Dursun B; Kavalci E
Ren Fail; 2016; 38(1):35-9. PubMed ID: 26627016
[TBL] [Abstract][Full Text] [Related]
19. Association of different iron deficiency cutoffs with adverse outcomes in chronic kidney disease.
Eisenga MF; Nolte IM; van der Meer P; Bakker SJL; Gaillard CAJM
BMC Nephrol; 2018 Sep; 19(1):225. PubMed ID: 30208847
[TBL] [Abstract][Full Text] [Related]
20. Hepcidin-25 in chronic hemodialysis patients is related to residual kidney function and not to treatment with erythropoiesis stimulating agents.
van der Weerd NC; Grooteman MP; Bots ML; van den Dorpel MA; den Hoedt CH; Mazairac AH; Nubé MJ; Penne EL; Gaillard CA; Wetzels JF; Wiegerinck ET; Swinkels DW; Blankestijn PJ; Ter Wee PM;
PLoS One; 2012; 7(7):e39783. PubMed ID: 22808058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
